KP-161 is an experimental antiviral drug being studied for the treatment of HIV/AIDS.

[1] It belongs to the class of nucleoside reverse transcriptase inhibitors.

[2] KP-1461 is a prodrug of the active antiviral agent KP-1212.

[3] This antiinfective drug article is a stub.

You can help Wikipedia by expanding it.